跳轉至內容
Merck
全部照片(1)

文件

ISEQ00010

Millipore

Immobilon® -PSQ PVDF Membrane

1 roll, 27 cm x 3.75 m, 0.2 µm pore size, transfer membrane for Western blotting

同義詞:

Western blotting membrane, blotting membrane, transfer membrane

登入查看組織和合約定價
全部照片(1)

About This Item

分類程式碼代碼:
41105339
eCl@ss:
32031602
NACRES:
NB.23

product name

Immobilon®-PSQ PVDF膜, 1 roll, 27 cm x 3.75 m, 0.2 µm pore size, Hydrophobic PVDF Transfer Membrane for western blotting.

材料

PVDF membrane
plain filter
white filter

品質等級

400

特點

hydrophobic

製造商／商標名

Immobilon®

技術

dot blot: suitable
western blot: suitable

過濾器長度 × 寬度

27 cm × 3.75 m

孔徑

0.2 μm pore size

容量

262 μg/cm2 adsorption capacity (insulin)
 340 μg/cm2 adsorption capacity (BSA)
 448 μg/cm2 adsorption capacity (goat IgG)

相容性

for use with Amido black
for use with CPTS
for use with Colloidal gold
for use with Coomassie brilliant blue
for use with India ink
for use with Ponceau-S red
for use with Sypro<TMSYMBOL></TMSYMBOL> ruby
for use with Toluidine blue
for use with Transillumination

檢測方法

chemiluminescent
colorimetric
radioactive

運輸包裝

ambient

相關類別

一般說明

Immobilon®-PSQ膜是由聚偏氟乙烯(PVDF)制成的0.2 μm微孔膜。该产品是为了最大化蛋白质结合而开发的。Immobilon®-PSQ膜推荐用于电泳凝胶电泳蛋白（或纯化蛋白样品的点结合）后的直接蛋白测序和免疫检测，特别是分子量小于20,000的蛋白。该滤膜兼容储水罐和半干法电印迹系统。

應用

Immobilon®-PSQ PVDF膜已用于蛋白质印迹分析。

特點和優勢

Immobilon®-PSQ膜：
  • 0.2 μm孔径和大内部结构
  • 蛋白质吸附和测序产量高于其他膜
  • 防止低分子量蛋白质的吹穿

法律資訊

Immobilon is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Bing Yan et al.
Theranostics, 10(15), 6728-6742 (2020-06-20)
Rational: Ischemic injury of the skeletal muscle remains a serious clinical problem and currently there is no effective therapy. The aim of the present study is to determine whether human umbilical cord mesenchymal stem cells- derived exosomes (UMSC-Exo) could repair
Chenggong Sun et al.
Journal of hematology & oncology, 13(1), 9-9 (2020-02-02)
PARP inhibitors have been the most promising target drugs with widely proven benefits among ovarian cancer patients. Although platinum-response, HR-related genes, or HRD genomic scar detection are acceptably used in assessment of Olaparib response, there are still evident limitations in
Chenshuo Luo et al.
Journal of oncology, 2020, 3676751-3676751 (2020-05-16)
To verify and evaluate the value of CD40 as a noninvasive biomarker of cisplatin-resistant bladder cancer, we studied the expression of CD40 and the correlation between nucleophosmin (NPM1) and CD40 in cisplatin-resistant bladder cancer. Three cisplatin-resistant bladder cancer cell lines
Carey Wilson et al.
Neuropharmacology, 168, 107998-107998 (2020-02-18)
Traditional monoaminergic treatments of depression frequently exhibit suboptimal tolerability and effectiveness. The 'short' (s) allele variant of 5-HTTLPR is known to compromise transcriptional efficacy of the serotonin transporter (5-HTT) and can reduce treatment response to traditional antidepressants (e.g. selective serotonin
Chi-Feng Weng et al.
Frontiers in physiology, 10, 1445-1445 (2020-01-11)
Adipose-derived stem cells (ADSCs) have shown great promise for the treatment of myocardial infarction (MI), although their potential therapeutic mechanism remains poorly understood. Growing evidence has implicated microRNAs (miRNAs or miRs) in the biological processes whereby ADSCs could ameliorate cardiovascular
查看所有相關論文

條款

Stripping and Reprobing Western Blotting Membranes

This page shows and discusses three protocols for stripping and reprobing a western blot membrane.

剝離和重新製備 Western Blotting 膜

本頁顯示並討論三種剝離和重新印製 western 印迹膜的方案。

細胞裂解與蛋白抽提以進行 Western 印迹分析

用於細胞裂解的樣品製備和從培養組織和細胞中高效提取蛋白質以進行隨後 Western 印跡的規程。

Cell Lysis and Protein Extraction for Western Blotting

Protocol for sample preparation for cell lysis and efficient protein extraction from cultured tissues and cells for subsequent Western blotting.

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務